Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pivot Pharmaceuticals Inc (PVOTF)

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,781
  • Shares Outstanding, K 171,414
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,020 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/15/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +104.46%
on 06/05/20
0.2588 -48.65%
on 05/18/20
+0.0229 (+20.82%)
since 05/05/20
3-Month
0.0301 +341.53%
on 03/23/20
0.2588 -48.65%
on 05/18/20
+0.0728 (+121.13%)
since 03/05/20
52-Week
0.0301 +341.53%
on 03/23/20
0.3800 -65.03%
on 07/15/19
-0.1868 (-58.43%)
since 06/04/19

Most Recent Stories

More News
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: PVOTF) (FSE: NPAT) is pleased to provide an update to its press release of whereby BetterLife announced...

BETR.CN : 0.175 (+2.94%)
PVOTF : 0.1329 (+2.23%)
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

VANCOUVER, BC , June 4, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: PVOTF) (FSE: NPAT) is pleased to provide an update to its press release of...

BETR : 12.00 (unch)
PVOTF : 0.1329 (+2.23%)
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum

,

PVOTF : 0.1329 (+2.23%)
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum

VANCOUVER , May 25, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) is pleased to announce that it has, as...

PVOTF : 0.1329 (+2.23%)
BETR : 12.00 (unch)
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board

, /PRNewswire/ -BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. to the Company's Scientific Advisory Board. Dr....

PVOTF : 0.1329 (+2.23%)
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board

VANCOUVER , May 19, 2020 /PRNewswire/ -   BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. Eleanor Fish...

PVOTF : 0.1329 (+2.23%)
BETR : 12.00 (unch)
BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that the journal Frontiers of Immunology ("") released the results of the...

PVOTF : 0.1329 (+2.23%)
BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

VANCOUVER , May 15, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that the journal Frontiers of Immunology ("...

BETR : 12.00 (unch)
PVOTF : 0.1329 (+2.23%)
BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that a third party study is scheduled to be released this Friday in the journal...

PVOTF : 0.1329 (+2.23%)
BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

VANCOUVER , May 13, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that a third party study is scheduled to be released...

BETR : 12.00 (unch)
PVOTF : 0.1329 (+2.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade PVOTF with:

Key Turning Points

2nd Resistance Point 0.1792
1st Resistance Point 0.1561
Last Price 0.1329
1st Support Level 0.0874
2nd Support Level 0.0418

See More

52-Week High 0.3800
Fibonacci 61.8% 0.2463
Fibonacci 50% 0.2050
Fibonacci 38.2% 0.1638
Last Price 0.1329
52-Week Low 0.0301

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar